Ads by Google

Blood Pressure

High Levels Of Urinary Albumin In Normal Range Predict Hypertension

2008-07-05 09:05

Healthy individuals with higher levels of albumin excretion, even levels considered normal, are at increased risk of developing hypertension (high blood pressure).

Because kidneys normally prevent large molecules such as albumin from being excreted in the urine, high levels of urinary albumin excretion— called albuminuria—can be an indicator of kidney damage. Albuminuria may also reflect dysfunction of endothelial cells throughout the body, which in turn may be a precursor to hypertension.

conditions: 

Men, Especially Blacks, More Likely To Miss Own Hypertension

2008-07-03 08:52

A new study suggests that American men are much more likely than women are to be unaware that they suffer from high blood pressure. African-American men with the condition are at the highest risk, with only one in seven both aware of their illness and able to control it through medication.

conditions: 

How Effective Is Hypertension Treatment Device?

2008-06-18 09:05

InterCure announced the findings of new studies and analysis highlighting RESPeRATE -- the only medical device cleared by the FDA and CE-approved for the treatment of hypertension. Five posters will be presented at the European Society of Hypertension meeting (ESH) in Berlin beginning June 14, 2008. Two of the five posters focus on RESPeRATE's effect on blood pressure as measured by 24-hour ambulatory blood pressure monitoring. Three of the posters also present new findings in the emerging field of obtaining vascular risk parameters from blood pressure measurements.

conditions: 

BENICAR Reverses Blood Vessel Damage Independent Of Blood Pressure Lowering

2008-06-16 13:03

Hypertension treatment olmesartan medoxomil was effective in reversing the narrowing of the arteries that occurs in patients with hypertension. The study, titled VIOS (Vascular Improvement with Olmesartan medoxomil Study) was a one-year, exploratory study that evaluated the effects of an angiotensin receptor blocker (olmesartan medoxomil) vs. a beta-blocker (atenolol) on vascular function and structure in patients with Stage 1 hypertension, independent of the blood pressure lowering effects of these agents.

conditions: 

Pages